White Coat Hypertension and Cardiovascular Diseases: Innocent or Guilty

Area of Science:

• Cardiology
• Hypertension Research
• Clinical Epidemiology

Background:

• White coat hypertension (WCH) is characterized by elevated blood pressure in a clinical setting but normal readings outside of it.
• The prognostic significance of WCH regarding cardiovascular outcomes remains a subject of ongoing research and debate.
• Understanding the cardiovascular risk associated with WCH is crucial for appropriate patient management.

Purpose of the Study:

• To clarify the cardiovascular risk associated with white coat hypertension (WCH).
• To synthesize evidence from meta-analyses and population-based studies on WCH and cardiovascular outcomes.
• To identify potential subgroups of WCH patients who may be at increased risk.

Main Methods:

• Review of multiple meta-analyses and population-based studies evaluating cardiovascular risk in WCH.
• Analysis of data from the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes study.
• Examination of a recent meta-analysis stratifying WCH subjects by antihypertensive treatment status.

Main Results:

• The International Database study found no increased cardiovascular risk in WCH patients, except in older, high-risk individuals.
• A recent meta-analysis indicated increased cardiovascular risk in untreated WCH subjects and mixed populations, but not in treated WCH subjects.
• Evidence suggests that WCH may have a prognostic impact, but this is not universal across all WCH patients.

Conclusions:

• The cardiovascular risk in white coat hypertension is variable and depends on factors such as treatment status and patient risk profile.
• Untreated WCH, particularly in certain subgroups, may be associated with adverse cardiovascular outcomes.
• Further research is warranted to identify specific WCH subgroups at higher risk and to assess the impact of therapeutic interventions.